Idine Mousavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Idine Mousavi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Mannan Khan Minhas
Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
1 shared publication - Anum Saeed
Heart and Vascular Institute, University of Pittsburgh Medical Center , Pittsburgh, PA
1 shared publication Arunima Misra
Section of Cardiology, Department of Medicine, Baylor College of Medicine , Houston, TX
1 shared publication- Christie M. Ballantyne
Department of Medicine, Baylor College of Medicine, Houston, TX (C.M.B.).
1 shared publication - Erin Donelly Michos
Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, USA
1 shared publication - John Suffredini
Section of Cardiology, Department of Medicine, Baylor College of Medicine , Houston, TX
1 shared publication
Latest Publications
- Open Access
- 6 August 2024
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 19, 100715
Bempedoic Acid in Secondary Prevention
- 6 August 2024
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 19, 100715
Open AccessBempedoic Acid in Secondary Prevention
- 23 July 2024
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 32 (2) , 100-112
Early-onset atherosclerotic cardiovascular disease
Recent trends indicate a concerning increase in early-onset atherosclerotic cardiovascular disease (ASCVD) among younger individuals (men aged <55 years women aged <65 years). These findings highlight the pathobiology of ASCVD as a disease process that begins early in life and underscores the need for more tailored screening methods and preventive strategies. Increasing attention has been placed on the growing burden of traditional cardiometabolic risk factors in young individuals while also recognizing unique factors that mediate risk of pre-mature atherosclerosis in this demographic such as substance use, socioeconomic disparities, adverse pregnancy outcomes, and chronic inflammatory states that contribute to the increasing incidence of early ASCVD. Additionally, mounting evidence has pointed out significant disparities in the diagnosis and management of early ASCVD and cardiovascular outcomes based on sex and race. Moving towards a more personalized approach, emerging data and technological developments using diverse tools such as polygenic risk scores and coronary artery calcium scans have shown potential in earlier detection of ASCVD risk. Thus, we review current evidence on causal risk factors that drive the increase in early ASCVD and highlight emerging tools to improve ASCVD risk assessment in young individuals.
- 23 July 2024
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 32 (2) , 100-112
Early-onset atherosclerotic cardiovascular disease
Recent trends indicate a concerning increase in early-onset atherosclerotic cardiovascular disease (ASCVD) among younger individuals (men aged <55 years women aged <65 years). These findings highlight the pathobiology of ASCVD as a disease process that begins early in life and underscores the need for more tailored screening methods and preventive strategies. Increasing attention has been placed on the growing burden of traditional cardiometabolic risk factors in young individuals while also recognizing unique factors that mediate risk of pre-mature atherosclerosis in this demographic such as substance use, socioeconomic disparities, adverse pregnancy outcomes, and chronic inflammatory states that contribute to the increasing incidence of early ASCVD. Additionally, mounting evidence has pointed out significant disparities in the diagnosis and management of early ASCVD and cardiovascular outcomes based on sex and race. Moving towards a more personalized approach, emerging data and technological developments using diverse tools such as polygenic risk scores and coronary artery calcium scans have shown potential in earlier detection of ASCVD risk. Thus, we review current evidence on causal risk factors that drive the increase in early ASCVD and highlight emerging tools to improve ASCVD risk assessment in young individuals.